Reimagining myth and ideology in Ne Zha 2 : A multimodal critical discourse analysis
Animation · 2026-11 · 21 (3) · 283-302
DOI: 10.1177/17468477261474069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animation, online erschienen am 29.10.2026. Verfasst von Changsong Wang. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Xiamen University Malaysia Research Fund.
Abstract (Originalsprache)
For the first time, a film from an Asian country has broken into the top 5 of the global box office, with Ne Zha 2 becoming the highest-grossing animated film worldwide. Centered on the Chinese mythological figure Ne Zha, the film demonstrates both technical sophistication and powerful narrative design. This study adopts apparatus theory to analyze both the technical apparatus and the institutional apparatus in order to understand the film’s ideological function within contemporary Chinese society. Employing multimodal critical discourse analysis, the study explores how Ne Zha 2 constructs and disseminates ideological narratives through visual storytelling, character development, and the reinterpretation of mythology. The findings contribute to a deeper understanding of how contemporary Chinese animation functions as a vehicle for ideological expression and cultural diplomacy, offering critical insights into the intersection of film, politics, and soft power in the context of China’s global media strategy.
Förderung
- Xiamen University Malaysia Research Fund
Zitieren
APA
Wang, C. (2026). Reimagining myth and ideology in Ne Zha 2 : A multimodal critical discourse analysis. Animation, 21(3), 283-302. https://doi.org/10.1177/17468477261474069
Vancouver
Wang C. Reimagining myth and ideology in Ne Zha 2 : A multimodal critical discourse analysis. Animation. 2026;21(3):283-302. doi:10.1177/17468477261474069
BibTeX
@article{Wang2026,
author = {Wang, Changsong},
title = {Reimagining myth and ideology in Ne Zha 2 : A multimodal critical discourse analysis},
journal = {Animation},
year = {2026},
volume = {21},
number = {3},
pages = {283--302},
doi = {10.1177/17468477261474069}
}
EUVIMED